XTX Topco’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-9,513
Closed -$270K 3902
2025
Q3
$270K Buy
+9,513
New +$258K 0.01% 1589
2025
Q2
Sell
-18,188
Closed -$564K 3300
2025
Q1
$564K Buy
+18,188
New +$606K 0.03% 940
2024
Q2
Sell
-14,364
Closed -$603K 2560
2024
Q1
$603K Buy
+14,364
New +$560K 0.08% 378
2023
Q2
Sell
-14,979
Closed -$546K 1914
2023
Q1
$546K Buy
+14,979
New +$524K 0.11% 242
2022
Q4
Sell
-7,900
Closed -$308K 1570
2022
Q3
$308K Buy
+7,900
New +$362K 0.08% 483

Other funds holding ASTH

XTX Topco's ASTH Position: Q4 2025 in Review

XTX Topco sold out of Astrana Health (ASTH) in Q4 2025, closing a stake of 9,513 shares — an estimated $270K sold.

XTX Topco first reported a position in ASTH in Q3 2022 and held it in 5 quarters. The position peaked at $603K in Q1 2024. 175 funds tracked by Wall St. Rank hold ASTH as of Q4 2025.

  • XTX Topco reported no remaining Astrana Health position as of Q4 2025 after selling out during the quarter.
  • XTX Topco sold 9,513 Astrana Health shares in Q4 2025, an estimated $270K.
  • XTX Topco first reported a position in Astrana Health in Q3 2022 and held it in 5 quarters.
  • XTX Topco's Astrana Health position peaked at $603K in Q1 2024.
  • 175 funds tracked by Wall St. Rank held Astrana Health as of Q4 2025.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.